Publicacions

Alternation of antiretroviral drug regimens for HIV infection. Efficacy, safety and tolerability at week 96 of the Swatch Study.

New antiretroviral drugs and approaches to HIV treatment.

Role of structured treatment interruption before a 5-drug salvage antiretroviral regimen: the Retrogene Study.

Virological, immunological, and clinical impact of switching from protease inhibitors to nevirapine or to efavirenz in patients with human immunodeficiency virus infection and long-lasting viral suppression.

Insertions in the reverse transcriptase increase both drug resistance and viral fitness in a human immunodeficiency virus type 1 isolate harboring the multi-nucleoside reverse transcriptase inhibitor resistance 69 insertion complex mutation.

Suppression of chemokine receptor expression by RNA interference allows for inhibition of HIV-1 replication.

Reversal of atherogenic lipoprotein profile in HIV-1 infected patients with lipodystrophy after replacing protease inhibitors by nevirapine.

Catalytic efficiency and phenotype of HIV-1 proteases encoding single critical resistance substitutions.

Antiretroviral treatment simplification with nevirapine in protease inhibitor-experienced patients with hiv-associated lipodystrophy: 1-year prospective follow-up of a multicenter, randomized, controlled study.

Psychological impact of structured treatment interruptions in patients with prolonged undetectable HIV-1 viral loads.